HNRNPA2B1-mediated m6A modification of lncRNA MEG3 promotes tumorigenesis and metastasis of NSCLC by regulating miR-21-5p/PTEN axis and may offer a new epigenetic regulatory mechanism and a potential therapeutic target for NSCLC. This evidence concerns the gene HNRNPA2B1 and non-small cell lung carcinoma.